3//SEC Filing
Apeiron Presight Capital Fund II, L.P. 3
Accession 0000950170-24-113341
CIK 0001194833other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 6:17 PM ET
Size
8.8 KB
Accession
0000950170-24-113341
Insider Transaction Report
Form 3
Apeiron Investment Group Ltd.
10% Owner
Holdings
- 93,369,060(indirect: By Apeiron Presight Capital Fund II, L.P.)
Ordinary Shares
- 183,121,441(indirect: By Apeiron Investment Group Ltd.)
Ordinary Shares
Footnotes (3)
- [F1]Includes Ordinary Shares represented by American Depositary Shares.
- [F2]The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.
- [F3]The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities.
Documents
Issuer
BIONOMICS LTD/ADR
CIK 0001194833
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001840676
Filing Metadata
- Form type
- 3
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 6:17 PM ET
- Size
- 8.8 KB